Physician profile
Daniel Edward Snow
NPI 1609876481
$1,943.30
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,605 · 2020: $154 · 2021: $57.16 · 2022: $32.93 · 2024: $93.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $304.56 | 2019-2024 | Mounjaro |
| Pfizer INC. | $301.89 | 2019 | |
| Merck Sharp & Dohme LLC | $243.54 | 2019 | |
| Novo Nordisk INC | $223.87 | 2019-2021 | |
| Abbvie INC. | $202.45 | 2019-2022 | |
| Allergan, INC. | $108.10 | 2019 | |
| Astellas Pharma US INC | $106.23 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $97.85 | 2019-2020 | |
| Optinose US, INC. | $87.64 | 2020 | |
| Janssen Pharmaceuticals, INC | $60.62 | 2019-2021 | |
| Horizon Therapeutics Plc | $36.28 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.45 | 2019 | |
| Amarin Pharma, INC. | $22.28 | 2019 | |
| Boston Scientific Corporation | $18.51 | 2019 | |
| Amgen INC. | $17.43 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $16.40 | 2019 | |
| Antares Pharma, INC. | $15.91 | 2019 | |
| Shire North American Group INC | $14.66 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.04 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.35 | 2019 | |
| Sanofi Pasteur INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Snow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.